Anna Rose Childress, Ph.d.
Clinical trials sponsored by Anna Rose Childress, Ph.d., explained in plain language.
-
Magic mushroom compound takes on opioid crisis in new trial
Disease control Recruiting nowThis study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) can help people with opioid use disorder reduce drug use and stick with their medication. Thirty-six adults on stable medication for opioid use will receive either a high or low dose o…
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
Brain scans reveal Psilocybin's effect on opioid addiction circuits
Knowledge-focused Recruiting nowThis study looks at how psilocybin (a psychedelic drug) changes brain activity related to motivation and self-control in people with opioid use disorder. Researchers will use brain scans (fMRI) to compare low and high doses in 24 adults aged 18-60. The goal is to understand brain…
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC